| Oncology Nation

Saved
Promoted

Breast Cancer Connect

1yr

Breast Cancer: Extracellular Matrix and Microbiome Interactions

Source : https://pubmed.ncbi.nlm.nih.gov/39000333/

Breast cancer represents the most prevalent form of cancer and the leading cause of cancer-related mortality among females worldwide. It has been reported that several risk factors contribute to the...

Understanding the interplay between the extracellular matrix and microbiome in breast cancer may reveal innovative treatment strategies and improve patient outcomes by targeting these emerging therapeutic avenues.

Saved
Promoted

Breast Cancer Connect

1yr

Immunotherapy in Breast Cancer

Source : https://pubmed.ncbi.nlm.nih.gov/39062758/

Breast cancer is a disease encompassing a spectrum of molecular subtypes and clinical presentations, each with distinct prognostic implications and treatment responses. Breast cancer has traditionally been considered an immunologically...

In summary, immunotherapy, particularly checkpoint inhibitors, is advancing the treatment of breast cancer, with promising clinical trials and biomarkers paving the way for personalized and effective therapies.

Saved
Promoted

Breast Cancer Connect

1yr

Did you know? The introduction of HPV vaccines has led to a dramatic reduction in cervical cancer rates, decreasing by 87% among women aged 20-24 who were vaccinated as preteens. These vaccines not only protect against cancer but also prevent other HPV-related conditions, marking a significant advancement in women’s health.

Could expanding HPV vaccination to broader age groups further reduce the global burden of cervical cancer?